LUZHU BIOTECH-B(02480)

25.350+0.450+1.81%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
LUZHU BIOTECH-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://luzhubiotech.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.

1D
5D
Day
Week
Month

Loading ...

High

25.500

Open

25.500

Volume%

0.11

Low

25.450

Close

24.900

T/O Rate

0.00%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"LUZHU BIOTECH-B(02480),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LUZHU BIOTECH-B(02480) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LUZHU BIOTECH-B,02480,LUZHU BIOTECH-B股票,LUZHU BIOTECH-B股票老虎,LUZHU BIOTECH-B股票老虎国际,LUZHU BIOTECH-B行情,LUZHU BIOTECH-B股票行情,LUZHU BIOTECH-B股价,LUZHU BIOTECH-B股市,LUZHU BIOTECH-B股票价格,LUZHU BIOTECH-B股票交易,LUZHU BIOTECH-B股票购买,LUZHU BIOTECH-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LUZHU BIOTECH-B(02480),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LUZHU BIOTECH-B(02480) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"community","symbol":"02480","data":{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"LUZHU BIOTECH-B","latestPrice":25.35,"timestamp":1742285291031,"preClose":24.9,"halted":0,"volume":3600,"delay":0,"floatShares":201013032,"shares":201013032,"eps":-1.3475665308894258,"marketStatus":"Not Yet Opened","change":0.45,"latestTime":"03-18 16:08:11","open":25.5,"high":25.5,"low":25.45,"amount":91730,"amplitude":0.002008,"askPrice":25.35,"askSize":400,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.485636722434169,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742347800000},"marketStatusCode":0,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":24.9,"openAndCloseTimeList":[[1742261400000,1742270400000],[1742274000000,1742284800000]],"volumeRatio":0.11221945161643895,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.9970000289","cardData":[{"tweetId":"9970000289","author":{"authorId":"4117346251195962","idStr":"4117346251195962","name":"Patrick goh","avatar":"https://community-static.tradeup.com/news/7e3b466ea2635cbcd38f9dc4dbf1a6e8","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.16","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":86,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://ttm.financial/S/02480\">$绿竹生物-B(02480)$ &nbsp;</a>","plainDigest":"$绿竹生物-B(02480)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1683680831242,"gmtModify":1683680834090,"symbols":["02480"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":159,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://ttm.financial/post/9970000289","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":19,"displayRows":4,"strategy":"timeline","authorId":"4117346251195962"}]}],"size":1,"extra":{"requestId":"4e038c4a785048cf852b1e5f568477bf"}},"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":0.0432},{"period":"1month","weight":0.1575},{"period":"3month","weight":0.014},{"period":"6month","weight":0.1267},{"period":"1year","weight":0.3342},{"period":"ytd","weight":0.1046}],"compareEarnings":[{"period":"1week","weight":0.0403},{"period":"1month","weight":0.0937},{"period":"3month","weight":0.2455},{"period":"6month","weight":0.3735},{"period":"1year","weight":0.4782},{"period":"ytd","weight":0.2333}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.","exchange":"SEHK","name":"LUZHU BIOTECH-B","nameEN":"LUZHU BIOTECH-B"},"aProfile":null}}}